JP2006348055A5 - - Google Patents

Download PDF

Info

Publication number
JP2006348055A5
JP2006348055A5 JP2006268736A JP2006268736A JP2006348055A5 JP 2006348055 A5 JP2006348055 A5 JP 2006348055A5 JP 2006268736 A JP2006268736 A JP 2006268736A JP 2006268736 A JP2006268736 A JP 2006268736A JP 2006348055 A5 JP2006348055 A5 JP 2006348055A5
Authority
JP
Japan
Prior art keywords
composition according
salt
less
boric acid
acid derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006268736A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006348055A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2006268736A priority Critical patent/JP2006348055A/ja
Priority claimed from JP2006268736A external-priority patent/JP2006348055A/ja
Publication of JP2006348055A publication Critical patent/JP2006348055A/ja
Publication of JP2006348055A5 publication Critical patent/JP2006348055A5/ja
Pending legal-status Critical Current

Links

JP2006268736A 2001-03-08 2006-09-29 アルギン酸含有組成物 Pending JP2006348055A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006268736A JP2006348055A (ja) 2001-03-08 2006-09-29 アルギン酸含有組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001064802 2001-03-08
JP2006268736A JP2006348055A (ja) 2001-03-08 2006-09-29 アルギン酸含有組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002061761A Division JP3974431B2 (ja) 2001-03-08 2002-03-07 アルギン酸含有組成物

Publications (2)

Publication Number Publication Date
JP2006348055A JP2006348055A (ja) 2006-12-28
JP2006348055A5 true JP2006348055A5 (enrdf_load_stackoverflow) 2008-04-17

Family

ID=37644235

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006268736A Pending JP2006348055A (ja) 2001-03-08 2006-09-29 アルギン酸含有組成物

Country Status (1)

Country Link
JP (1) JP2006348055A (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008082948A2 (en) * 2006-12-29 2008-07-10 Bausch & Lomb Incorporated Ophthalmic alginate composition related methods of manufacture and methods of use
JP5258329B2 (ja) * 2007-06-01 2013-08-07 ロート製薬株式会社 プラノプロフェン含有水性医薬組成物
JP5620168B2 (ja) * 2010-06-30 2014-11-05 Dsp五協フード&ケミカル株式会社 キシログルカン−カチオン複合体及びそれを含有する安定化組成物
JP6213715B2 (ja) * 2013-06-27 2017-10-18 キョーリンリメディオ株式会社 多成分配合点眼剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601132A1 (de) * 1986-01-16 1987-07-23 Christian Bannert Verfahren zur behandlung der schleimhaut
CA2044878C (en) * 1990-08-07 2000-12-26 Tacey X. Viegas Thermally reversible and irreversible gels
JP2001228445A (ja) * 2000-12-13 2001-08-24 Rohto Pharmaceut Co Ltd コンタクトレンズ用溶剤

Similar Documents

Publication Publication Date Title
NO20065878L (no) Terapeutiske forbindelser
JP2016539144A5 (enrdf_load_stackoverflow)
RU2008150776A (ru) Продолжительное 24-часовое введение в кишечник леводопа/кардбидопа
WO2007115039A3 (en) Multi-cartridge fluid delivery device
PE20010531A1 (es) Sales farmaceuticas de la sustancia activa tramadol y al menos un edulcorante y formas de administracion que contienen estas sales
JP2007238598A5 (enrdf_load_stackoverflow)
CA2515293A1 (en) Eicosapentaenoic acid for use in improving prognosis in the treatment of subarachnoid hemorrhage
BR112014012522A2 (pt) método para encher um reservatório, reservatório e conjunto para encher um reservatório
PE20110711A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmaceuticamente aceptables de la misma
JP2006348055A5 (enrdf_load_stackoverflow)
CL2013003630A1 (es) Formulacion farmaceutica liquida que comprende nitisinona y un tampon de acido citrico que tien un ph en el rango de 2,5 a 3,5, de preferencia 3,0; y su uso para el tratamiento de tirosemia, enfermedad de parkinson, depresion, entre otros.
BRPI0411936A (pt) composto, processo para a sua preparação, composição farmacêutica que comprende o mesmo, utilização de um composto, métodos para o tratamento e profilaxia de distúrbios do sistema nervoso central, alimentares e obesidade
CN1984645A (zh) 在精神分裂症患者中作为非典型抗精神病药物的辅助治疗的美金刚
JP2020531511A5 (enrdf_load_stackoverflow)
JP2019147843A (ja) 吃音を治療するための融合ベンズアゼピン
BRPI0515815B8 (pt) forma medicamentosa de multipartículas contendo substâncias ativas de ácido nucléico formuladas mucoadesivas, bem como seu processo de preparação
CN105434351B (zh) 一种复方醋酸氟轻松喷雾剂及其制备方法
Ozcanli et al. Sertraline-and mirtazapine-induced severe neutropenia
JP4276841B2 (ja) 精神病性障害の予防もしくは治療における使用のためのカルバメート化合物
ES2323646T3 (es) Uso de derivados de pirrol contra la ansiedad.
US20070219201A1 (en) Combination of atomoxetine and a 5ht1a receptor agonist for treating adhd and other disorders
CN205626700U (zh) 一种肛肠科给药器
AR038198A1 (es) Usos farmaceuticos de un inhibidor de cox-2
CN201012212Y (zh) 一种改进的经鼻吸入器
CN201135545Y (zh) 方便滴眼器